Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study
Jun Te Hsu*, Puo Hsien Le, Chang Fu Kuo, Meng Jiun Chiou, Chia Jung Kuo, Tsung Hsing Chen, Chun Jung Lin, Jen Shi Chen, Huang Pin Yu, Chun Nan Yeh, Yi Yin Jan, Ta Sen Yeh
深入研究「Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study」主題。共同形成了獨特的指紋。